IamPsychiatry Highlights ADHD Treatment Gap After Diagnosis as Patients Face Further Waits for Medication

Sep 29, 2026

UK private mental health clinic draws attention to the period between receiving an adult ADHD diagnosis and beginning medication treatment, as NHS England calls for improvements across ADHD assessment and care.

LUTON, United Kingdom, September 29, 2026 -- For adults seeking help with ADHD, receiving a diagnosis may not mark the end of the waiting process. IamPsychiatry is highlighting the additional treatment stage that can follow diagnosis, as patients may still need specialist medication assessment, titration and ongoing monitoring before establishing a stable treatment plan.

The issue comes as NHS England continues work to improve ADHD services following the publication of its independent ADHD Taskforce report. The taskforce identified significant pressures across ADHD diagnosis and treatment, with NHS England acknowledging that referrals have risen substantially while waiting lists and waiting times have grown.

Its findings also drew attention to treatment access after diagnosis. According to the taskforce's December 2025 summary, only an estimated 15% of adults with ADHD receive medication, while the full report identified variation in prescribing and access to ongoing ADHD services across England.

For patients considering alternatives to prolonged waits, UK-based mental health clinic IamPsychiatry provides both private adult ADHD assessment and medication management services, allowing eligible patients to continue from diagnosis into treatment under consultant psychiatric care.

ADHD Care Can Continue Well Beyond Diagnosis

An ADHD diagnosis establishes whether a patient meets the relevant diagnostic criteria, but medication treatment involves a separate clinical process.

Titration is used to introduce and adjust ADHD medication while monitoring its effects, tolerability and possible side effects. The process can require repeated reviews before a suitable medication and dosage are established.

IamPsychiatry also offers private ADHD titration to adults who have already received an ADHD diagnosis elsewhere, meaning patients do not necessarily need to repeat their diagnostic assessment before approaching the clinic for medication management.

According to the clinic, ADHD medication titration and stabilisation typically take at least three months. Treatment decisions are made individually and medication is not considered appropriate for every patient.

The process includes assessment of the patient's existing diagnosis, medical information and treatment needs, followed where clinically appropriate by prescribing, monitoring and dosage adjustment.

Private Care Gives Patients Another Route Into Treatment

IamPsychiatry currently lists its adult ADHD screening, diagnostic assessment and treatment planning service from £1000. Its private ADHD medication titration assessment and treatment plan starts from £450.

Different appointment options are available depending on urgency, eligibility and availability. Patients who already have a diagnosis can currently book a titration assessment within eight weeks at the clinic's standard rate, with faster out-of-hours options also available.

Additional costs can apply during treatment, including private prescriptions, medication purchased from a pharmacy, follow-up consultations and medical documentation.

The clinic advises patients to consider the entire potential treatment journey when comparing private ADHD services rather than looking only at the price or speed of the initial diagnostic appointment.

This includes whether ongoing medication monitoring is available, how titration is handled, what follow-up support is provided and how future communication with the patient's GP may work.

Private Treatment May Later Involve a Patient's GP

Once medication has been successfully titrated and a patient's treatment has stabilised, ongoing prescribing may sometimes be transferred to primary care through a shared-care arrangement.

IamPsychiatry can provide supporting medical documentation and a proposed shared-care agreement when appropriate. Acceptance remains entirely at the discretion of the patient's GP, and the clinic advises patients to check their GP's requirements before relying on shared care as part of their longer-term treatment plan.

The clinic's approach also incorporates non-medication support. Patients may receive information about psychosocial interventions and other mental health resources alongside psychiatric assessment and medication management.

The emphasis reflects a wider point raised by the NHS England ADHD Taskforce, which recommended improving access to appropriate treatment while avoiding an approach in which medication is treated as the only form of support.

About IamPsychiatry

IamPsychiatry is a UK-based private mental healthcare service led by GMC-registered Consultant Psychiatrist Dr Iqbal Mohiuddin. The clinic provides online and face-to-face psychiatric assessments, counselling and treatment, with services covering Adult ADHD, anxiety, depression, PTSD and other mental health conditions.

IamPsychiatry provides Adult ADHD screening, diagnostic assessment, treatment planning and medication titration alongside wider psychiatric care.

For more information, visit:

https://www.iampsychiatry.uk/

Contact Info:
Name: Dr Iqbal Mohiuddin
Email: Send Email
Organization: IamPsychiatry
Address: Treetops, Wendover Way Luton LU2 7LS United Kingdom
Phone: 0800 779 7800
Website: https://www.iampsychiatry.uk/

Release ID: 89204647

In case of detection of errors, concerns, or irregularities in the content provided in this press release, or if there is a need for a press release takedown, we strongly encourage you to reach out promptly by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our efficient team will be at your disposal for immediate assistance within 8 hours – resolving identified issues diligently or guiding you through the removal process. We take great pride in delivering reliable and precise information to our valued readers.

More News
China’s proposed AI tech export bans may create short-term costs, long-term gains: analysts

China’s proposed AI tech export bans may create short-term costs, long-term gains: analysts

China’s proposed export bans and controls of artificial intelligence technologies aim to tighten Beijing’s grip in the strategically vital sector, casting a cloud over the commercial prospects of domestic model developers in the global AI race, analysts say. The new measures come as concerns mount globally over the risks of advanced AI systems, following a string of recent cyberattacks, while also underscoring AI’s growing national security importance for both Beijing and Washington. Zhang Yi,...

Read more
MALFEX npm Package 'imgdecode' Hides Shellcode Loader in Windows Native Addon

MALFEX npm Package 'imgdecode' Hides Shellcode Loader in Windows Native Addon

Cybersecurity researchers have discovered a malicious npm package that's part of a recently disclosed software supply chain attack campaign dubbed MALFEX. The package, named "imgdecode," was uploaded to the package registry on September 30, 2026, by a user named "malfexteste8." It has been downloaded 979 times as of writing and is still available on npm as of writing. The latest version of

Read more
Why Mars looks blue in NASA's unedited curiosity panorama?

Why Mars looks blue in NASA's unedited curiosity panorama?

Why Mars looks blue in NASA’s unedited curiosity panorama?Stand beside Curiosity at dawn, and you wouldn't see a red planet or a blue one. You'd see murky light-tan cliffs and almost no colour in the shadows. That makes NASA's new blue Mars panorama a bit of a trick, though not the kind you...

Read more
AI race may depend more on access to power, infrastructure than chip supply: Morgan Stanley

AI race may depend more on access to power, infrastructure than chip supply: Morgan Stanley

The global race to expand artificial intelligence (AI) capabilities could increasingly be determined by which companies can secure enough electricity, financing and data-centre infrastructure to operate advanced chips, rather than simply by their ability to acquire the latest technology, according to a Morgan Stanley research report.

Read more
iPhone 17 at  ₹54,000; 17Pro at  ₹57,000? Here's how you can get the iPhone 17 and 17 Pro at half the price

iPhone 17 at ₹54,000; 17Pro at ₹57,000? Here's how you can get the iPhone 17 and 17 Pro at half the price

Flipkart and Reliance Digital are offering discounts, bank benefits, and exchange deals on the iPhone 17 and iPhone 17 Pro. Here’s how the offers work, which conditions buyers must meet, and why the final savings depend on the phone exchanged and the payment method used.

Read more
For a Mere $2 Million, You Could Own Three Books That Unlocked the Universe

For a Mere $2 Million, You Could Own Three Books That Unlocked the Universe

At Sotheby’s, a feast of rare science books includes volumes from Copernicus, Galileo and Newton that together revolutionized human understanding of the cosmos.

Read more
Beijing Agreement advances global vocational education cooperation

Beijing Agreement advances global vocational education cooperation

Beijing Agreement advances global vocational education cooperation

Read more
AI could give small businesses competitive edge over large firms: Former UK PM Rishi Sunak

AI could give small businesses competitive edge over large firms: Former UK PM Rishi Sunak

Artificial intelligence (AI) could give small businesses a competitive advantage over large companies by helping them improve productivity, overcome resource constraints and adopt new technologies faster, former UK Prime Minister Rishi Sunak said.

Read more
Reporter’s notebook: Kimi’s AI credit card turns spending into computing quotas – with limits

Reporter’s notebook: Kimi’s AI credit card turns spending into computing quotas – with limits

China’s artificial intelligence companies have spent years persuading consumers to pay for their technology. Now, Moonshot AI, the start-up behind Kimi, is taking a different approach: offering AI computing benefits through a credit card. The company has teamed up with the Agricultural Bank of China (ABC) and American Express for what it calls “the world’s first AI native credit card”. After getting one for myself, the experience offered an intriguing way to bring AI services into everyday...

Read more
Why new energy storage needs international cooperation

Why new energy storage needs international cooperation

Why new energy storage needs international cooperation

Read more
United Now Offers Starlink Wi-Fi on Nearly Half its Daily Flights, Launches New “Starlink Tracker”

United Now Offers Starlink Wi-Fi on Nearly Half its Daily Flights, Launches New “Starlink Tracker”

Starlink Wi-Fi continues to make a huge difference in the travel experience for millions of United customers, and today the airline announced that it is now on nearly half its daily departures, launched a new digital Starlink tracker tool that lets travelers check if Starlink is on their upcoming flight, and extended its new “Switch to Better Wi-Fi” status match campaign to October 22. The new Starlink tracker – StarlinkTracker.United.com – was created in response to customer demand and takes users behind the scenes of United’s Starlink rollout. The stats on the site are updated daily and visitors can:

Read more
IRENA Coalition head urges global teamwork as energy storage grows

IRENA Coalition head urges global teamwork as energy storage grows

IRENA Coalition head urges global teamwork as energy storage grows

Read more

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

About Us

Delivering news from all over the globe, StarJournal keeps you abreast with the greatest minds in science, be it researchers, theorists or even popularizers.